ERASE CDI 2

This study will be performed to determine if previously described criteria (ERASE) can predict Clostridium difficile colonization in patients admitted to the hospital and to determine the overall rate.

August 09, 2017

  • Clinical Trial Information

    Trial Contact: Rothrock, Steven MD

    Trial Phone:

  • Age Group: Adult

    Phase: Not applicable

    Principal Investigator: Steven G. Rothrock, MD

    Sub Investigators: N/A

    IRB No: 15.034.03

    Secondary Protocol No:

    Applicable Disease Sites: None